Sphingolipids in anticancer therapy

被引:32
作者
Padrón, JM
机构
[1] Hosp Univ NS Candelaria, Inst Canario Invest Canc, Unidad Invest, Santa Cruz de Tenerife 38010, Spain
[2] Red Temat Invest Cooperat Ctr Canc, Inst Canario Invest Canc, Santa Cruz de Tenerife 38010, Spain
[3] Univ La Laguna, Inst Univ Bioorgan Antonio Gonzalez, E-38206 San Cristobal la Laguna, Spain
关键词
sphingolipid analogs; sphingosine; ceramide; apoptosis; signal transduction; anticancer drugs; structure-activity relationships; drug design;
D O I
10.2174/092986706776055553
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingolipids constitute a broad class of compounds with many biological functions. The sphingolipid metabolites ceramide and sphingosine are potent apoptosis inducers and produce cell cycle arrest, whereas sphingosine-1-phosphate promotes cellular growth and differentiation. Herein, the effects of sphingolipids and their analogs on diverse signaling pathways implicated in the apoptotic process are highlighted. The relatively simple chemical structure of these compounds has led to several strategies for their total synthesis. Those methods have contributed to the development and biological study of several analogs that present diverse degree of modification from the original structure. This article catalogues many of the recently developed synthetic analogs that act on diverse aspects of sphingolipid metabolism. A description of known enzyme inhibitors of the sphigolipids pathway is also given. Finally, diverse new sphingolipid-like antitumor agents isolated from marine sources are presented. This contribution opens the way for future development of new sphingolipid analogs that might be useful in cancer chemotherapy.
引用
收藏
页码:755 / 770
页数:16
相关论文
共 168 条
  • [131] Synthesis of novel and non-natural ceramide analogues derived from L-glutamic acid
    Shikata, K
    Azuma, H
    Tachibana, T
    Ogino, K
    [J]. TETRAHEDRON, 2002, 58 (29) : 5803 - 5809
  • [132] Shirahama T, 1997, CLIN CANCER RES, V3, P257
  • [133] Sphingosine induces apoptosis in androgen-independent human prostatic carcinoma DU-145 cells by suppression of bcl-X-L gene expression
    Shirahama, T
    Sakakura, C
    Sweeney, EA
    Ozawa, M
    Takemoto, M
    Nishiyama, K
    Ohi, Y
    Igarashi, Y
    [J]. FEBS LETTERS, 1997, 407 (01) : 97 - 100
  • [134] Cholesterol, lipid rafts, and disease
    Simons, K
    Ehehalt, R
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (05) : 597 - 603
  • [135] Sphingosine-1-phosphate: An enigmatic signalling lipid
    Spiegel, S
    Milstien, S
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (05) : 397 - 407
  • [136] Sphingosine-1-phosphate in cell growth and cell death
    Spiegel, S
    Cuvillier, O
    Edsall, LC
    Kohama, T
    Menzeleev, R
    Olah, Z
    Olivera, A
    Pirianov, G
    Thomas, DM
    Tu, ZX
    Van Brocklyn, JR
    Wang, F
    [J]. SPHINGOLIPIDS AS SIGNALING MODULATORS IN THE NERVOUS SYSTEM, 1998, 845 : 11 - 18
  • [137] Stewart ME, 1999, J LIPID RES, V40, P1434
  • [138] Novel ceramide analogs as potential chemotherapeutic agents in breast cancer
    Struckhoff, AP
    Bittman, R
    Burow, ME
    Clejan, S
    Elliott, S
    Hammond, T
    Tang, Y
    Beckman, BS
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (02) : 523 - 532
  • [139] The first synthesis of the anhydrophytosphingosine pachastrissamine (jaspine B) from Garner's aldehyde
    Sudhakar, N
    Kumar, AR
    Prabhakar, A
    Jagadeesh, B
    Rao, BV
    [J]. TETRAHEDRON LETTERS, 2005, 46 (02) : 325 - 327
  • [140] Sweeney EA, 1996, INT J CANCER, V66, P358, DOI 10.1002/(SICI)1097-0215(19960503)66:3<358::AID-IJC16>3.0.CO